Phenominer Database Results (12 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Site Method Duration Post Insult Time Value Record ID Study ID
LEW.1F post-insult time to onset of experimental arthritis pristane (150 ul) Olofsson P, et al., Arthritis Rheum 2002 Jan;46(1):259-68. joint integrity trait both 56 days-234 days 11 17.0 d 0.9 3.0 in vivo visual assessment 1.296E7 0 70133 1282
DA/ZtmRhd percentage of study population developing experimental arthritis during a period of time pristane (150 ul) Olofsson P, et al., Arthritis Rheum 2002 Jan;46(1):259-68. joint integrity trait both 56 days-234 days 10 100.0 % in vivo visual assessment 1.296E7 0 70128 1282
E3 post-insult time to onset of experimental arthritis pristane (150 ul) Olofsson P, et al., Arthritis Rheum 2002 Jan;46(1):259-68. joint integrity trait both 56 days-234 days 10 0.0 d in vivo visual assessment 1.296E7 0 70132 1282
DA/ZtmRhd post-insult time to onset of experimental arthritis pristane (150 ul) Olofsson P, et al., Arthritis Rheum 2002 Jan;46(1):259-68. joint integrity trait both 56 days-234 days 10 14.0 d 0.32 1.0 in vivo visual assessment 1.296E7 0 70131 1282
E3 subjects with ankylosis to total subjects with arthritis ratio pristane (150 ul) Olofsson P, et al., Arthritis Rheum 2002 Jan;46(1):259-68. joint integrity trait both 56 days-234 days 10 0.0 % in vivo visual assessment tail 1.296E7 0 70136 1282
DA/ZtmRhd arthritic paw count pristane (150 ul) Olofsson P, et al., Arthritis Rheum 2002 Jan;46(1):259-68. joint integrity trait both 56 days-234 days 10 3.7 null 0.16 0.5 in vivo visual assessment tail 1.296E7 0 70137 1282
LEW.1F subjects with ankylosis to total subjects with arthritis ratio pristane (150 ul) Olofsson P, et al., Arthritis Rheum 2002 Jan;46(1):259-68. joint integrity trait both 56 days-234 days 11 0.0 % in vivo visual assessment tail 1.296E7 0 70135 1282
DA/ZtmRhd subjects with ankylosis to total subjects with arthritis ratio pristane (150 ul) Olofsson P, et al., Arthritis Rheum 2002 Jan;46(1):259-68. joint integrity trait both 56 days-234 days 10 75.0 % in vivo visual assessment tail 1.296E7 0 70134 1282
E3 arthritic paw count pristane (150 ul) Olofsson P, et al., Arthritis Rheum 2002 Jan;46(1):259-68. joint integrity trait both 56 days-234 days 10 0.0 null in vivo visual assessment tail 1.296E7 0 70139 1282
LEW.1F percentage of study population developing experimental arthritis during a period of time pristane (150 ul) Olofsson P, et al., Arthritis Rheum 2002 Jan;46(1):259-68. joint integrity trait both 56 days-234 days 11 100.0 % in vivo visual assessment 1.296E7 0 70129 1282
E3 percentage of study population developing experimental arthritis during a period of time pristane (150 ul) Olofsson P, et al., Arthritis Rheum 2002 Jan;46(1):259-68. joint integrity trait both 56 days-234 days 10 0.0 % in vivo visual assessment 1.296E7 0 70130 1282
LEW.1F arthritic paw count pristane (150 ul) Olofsson P, et al., Arthritis Rheum 2002 Jan;46(1):259-68. joint integrity trait both 56 days-234 days 11 3.4 null 0.21 0.7 in vivo visual assessment tail 1.296E7 0 70138 1282